Innovative multifunctional and smart coatings to prevent medical device related infectionsbroad
SPARTHACUS · Horizon Europe grant · 2022-08-01–2025-07-31
EC contribution
Total cost
Beneficiaries
About the data
Source: CORDIS (official EU open data), Horizon Europe. Framework HORIZON · call HORIZON-EIC-2021-ACCELERATOROPEN-01 · scheme HORIZON-EIC-ACC-BF · topic HORIZON-EIC-2021-ACCELERATOROPEN-01. CORDIS record →
Objective
Infections represent one of the major risks of surgery implants and the main cause of implant rejection, affecting over 5% of patients who undergo an implant surgery (around 2M patients in the EU). At SPARTHA Medical, created in 2019 as a spin-off of INSERM Biomaterials Unit (Strasbourg), we developed a multifunctional coating with antimicrobial and anti-inflammatory properties to prevent infections in implants and surgical care. In addition to this medical coating to be used directly in hospitals, we developed a second product a biocompatible, eco-friendly spray with antibacterial & antiviral properties for general and daily use. We also offer a customized coating development service for medical device manufacturers which leads to recurring licensing. Our coating platform is so versatile the applications are endless. We are also integrating the development service to electronics and cosmetics companies. We have signed 7 contract agreements so far, and 2 more in advanced negotiations.
Beneficiaries (1)
| Organisation | Country | Role | EC contribution | SME |
|---|---|---|---|---|
| SPARTHA MEDICAL | FR | coordinator | €2,389,625 | Yes |
Get the DFM funding briefing — free
New EU defence calls, tenders and awards in your inbox.
Defence Finance Monitor is an analytical and informational product. Grant data is official CORDIS; payment and subscription happen on DFM Analysis.